FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

BLISSGVS Share Price Discussion

Bliss GVS Pharma Ltd.
NSE: BLISSGVS | BSE: 506197 | ISIN: INE416D01022 | Sector: Pharmaceuticals and health care

BLISSGVS Rating

0/5 (0 Ratings)
BLISSGVS Share Price *
125.45 +1.2 (0.97%)
* (quote may be delayed)
Find answers to all your questions on live BLISSGVS message board: Is BLISSGVS buy or sell? Should I buy BLISSGVS shares? Why are BLISSGVS shares falling? Should I invest in BLISSGVS stock?

You can also check BLISSGVS share price target recommended by brokerages.

BLISSGVS Discussion Forum

@RISHABHTYAGI • Reputation: 4,623

**BUY BLISS CMP 150 TG 170-190 7-15% UPSIDE TARGETS**
Like
reply
Reply
@RISHABHTYAGI • Reputation: 4,623

*Another pick coming for 7-15% upside*
*Be ready guys*
Like
reply
Reply
@guptan • Reputation: 3,188

BLISSGVS - chart - 474417
BLISSGVS
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
  • BLISSGVS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,855.28
    Enterprise Value1,828.99
    Price to Earnings35.33
    Price to Book Value3.08
    Return on Capital Employed0.15
    Return on Equity0.11
    Face Value1
    Dividend Yield0.01
  • BLISSGVS Share Price - Technicals

    keyboard_arrow_down
    BLISSGVS - 52 Week High₹183.7
    BLISSGVS - 52 Week Low₹73.75
  • BLISSGVS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    15-Mar-18Choice Equity BrokingBuy235.5
    9-Jan-18Joindre Capital ServicesBuy350
    27-Dec-17Choice Equity BrokingBuy262.5
    BLISSGVS Brokerage Price Target
  • BLISSGVS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 27128.4131120.5124.25
    Feb 26135.8138.4124.6128.15
    Feb 25138.35139.5135136.35
    Feb 24138.8141.6136137.35
    Feb 20142.6142.6137.8139.7
  • BLISSGVS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹139.05
    30 Day Moving Average₹141.15
    50 Day Moving Average₹144.27
    100 Day Moving Average₹139.77
    200 Day Moving Average₹137.59
  • BLISSGVS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue298349.18-0.15
    Operating Profit8991.75-0.03
    Profit Before Tax8798.42-0.12
    Net Income5762.6-0.09
  • BLISSGVS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds6035410.11
    Total Liabilities132153-0.14
    Total Assets7366940.06
  • BLISSGVS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2334.79-0.34
    Cash from Investing Activity22-26.56-1.83
    Cash from Financing Activity-22-13.850.59
    Net Cash Flow23-5.63-5.09
  • BLISSGVS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.1
    Return on Equity0.110.13
    Return on Capital Employed0.150.2
  • BLISSGVS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.05
    3 Year CAGR Growth in Operating Profit0.03
    3 Year CAGR Growth in EBIDTA-0.07
    3 Year CAGR Growth in Net Income-0.05
    3 Yr CAGR Growth - Diluted EPS-0.05
  • BLISSGVS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.16
    5 Year CAGR Growth in Operating Profit-0.12
    5 Year CAGR Growth in EBIDTA-0.14
    5 Year CAGR Growth in Net Income0.01
    3 Yr CAGR Growth - Diluted EPS0.01
  • BLISSGVS - Recent News

    keyboard_arrow_down
  • BLISSGVS - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.